MARKET

BPMC

BPMC

Blueprint Medicines Corp
NASDAQ
92.59
-1.35
-1.44%
Opening 11:31 02/18 EST
OPEN
93.73
PREV CLOSE
93.94
HIGH
95.10
LOW
92.36
VOLUME
333.45K
TURNOVER
--
52 WEEK HIGH
121.90
52 WEEK LOW
72.24
MARKET CAP
5.92B
P/E (TTM)
-86.7516
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BPMC last week (0210-0214)?
Weekly Report · 1d ago
Cautious Optimism: Hold Rating Given to Blueprint Medicines Amid Financial Performance Concerns and Slower Ayvakit Growth Projections
TipRanks · 1d ago
BPMC Q4 Earnings and Sales Miss Estimates, Shares Decline
NASDAQ · 3d ago
Blueprint Medicines Price Target Maintained With a $125.00/Share by JMP Securities
Dow Jones · 4d ago
JMP Securities Reiterates Market Outperform on Blueprint Medicines, Maintains $125 Price Target
Benzinga · 4d ago
Morgan Stanley Sticks to Their Hold Rating for Blueprint Medicines (BPMC)
TipRanks · 4d ago
Blueprint Medicines Price Target Maintained With a $133.00/Share by Needham
Dow Jones · 4d ago
Needham Reiterates Buy on Blueprint Medicines, Maintains $133 Price Target
Benzinga · 4d ago
More
About BPMC
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib), to patients in the United States and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer, breast cancer and other genomically defined cancers, and cancer immunotherapy. Its pipelines also include Elenestinib (BLU-263) (KIT), AYVAKIT (avapritinib) (KIT), Wild-type KIT research program, GAVRETO (pralsetinib) (RET), BLU-945 (EGFR), BLU-525 (EGFR), BLU-451 (EGFR exon 20 insertions), BLU-222 (CDK2), AYVAKIT (PDGFRA), GAVRETO (RET), BLU-222 (CDK2) and BLU-852 (MAP4K1). It is developing elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders.

Webull offers Blueprint Medicines Corp stock information, including NASDAQ: BPMC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BPMC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BPMC stock methods without spending real money on the virtual paper trading platform.